Data / Form D filings / Quince Therapeutics, Inc.
Quince Therapeutics, Inc.: Form D filings
Quince Therapeutics, Inc., a biotechnology company in South San Francisco, CA, filed 6 Form D notices with the SEC between 2016 and 2026. The latest, on June 11, 2026, reports an offering of $7.4 million with nothing sold yet to 66 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 611 Gateway Blvd., Suite 273, South San Francisco, CA, 94080
- Phone
- (415) 910-5717
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1662774
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | New notice | $7,387,671 | $0 | $7,387,671 | 66 | May 18, 2026 | sec.gov |
| Jun 11, 2026 | New notice | $186,422,679 | $114,720,542 | $71,702,137 | 27 | May 18, 2026 | sec.gov |
| Jul 1, 2025 | New notice | $21,896,618 | $11,488,304 | $10,408,314 | 15 | Jun 18, 2025 | sec.gov |
| May 31, 2018 | New notice | $85,566,697 | $84,466,700 | $1,099,997 | 36 | May 23, 2018 | sec.gov |
| Feb 14, 2017 | New notice | $8,000,000 | $7,600,000 | $400,000 | 8 | Feb 1, 2017 | sec.gov |
| Jan 5, 2016 | New notice | $15,918,641 | $7,918,642 | $7,999,999 | 13 | Dec 22, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dirk Thye | Executive Officer, Director | |
| Brigette Roberts | Executive Officer, Director | |
| Charles Ryan | Executive Officer | |
| Brendan Hannah | Executive Officer | |
| David Lamond | Director | |
| Christopher Senner | Director | |
| June Bray | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 8, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Quince Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.